Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Immuneering (NASDAQ:IMRX).
Unicycive Therapeutics has a consensus price target of $5.50.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.6528 last updated January 21, 2025 at 7:46 PM EST.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q4 earnings are confirmed for Thursday, March 27, 2025.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.